BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21653685)

  • 21. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
    Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.
    Christiansen D; Milland J; Mouhtouris E; Vaughan H; Pellicci DG; McConville MJ; Godfrey DI; Sandrin MS
    PLoS Biol; 2008 Jul; 6(7):e172. PubMed ID: 18630988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstitution models to evaluate natural killer T cell function in tumor control.
    Gebremeskel S; Slauenwhite D; Johnston B
    Immunol Cell Biol; 2016 Jan; 94(1):90-100. PubMed ID: 26095148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chewing the fat on natural killer T cell development.
    Godfrey DI; McConville MJ; Pellicci DG
    J Exp Med; 2006 Oct; 203(10):2229-32. PubMed ID: 17000869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity.
    Fujii S; Goto A; Shimizu K
    Blood; 2009 Apr; 113(18):4262-72. PubMed ID: 19164596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunological function of iGb3.
    Zhou D
    Curr Protein Pept Sci; 2006 Aug; 7(4):325-33. PubMed ID: 16918447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
    Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD1d-restricted IFN-γ-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells.
    Kim JH; Chung DH
    J Immunol; 2011 Feb; 186(3):1432-41. PubMed ID: 21191075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type I IFN-producing CD4 Valpha14i NKT cells facilitate priming of IL-10-producing CD8 T cells by hepatocytes.
    Wahl C; Bochtler P; Schirmbeck R; Reimann J
    J Immunol; 2007 Feb; 178(4):2083-93. PubMed ID: 17277112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biology of NKT cells.
    Bendelac A; Savage PB; Teyton L
    Annu Rev Immunol; 2007; 25():297-336. PubMed ID: 17150027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
    J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells.
    Schrantz N; Sagiv Y; Liu Y; Savage PB; Bendelac A; Teyton L
    J Exp Med; 2007 Apr; 204(4):841-52. PubMed ID: 17389239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The NKT cell TCR repertoire can accommodate structural modifications to the lipid and orientation of the terminal carbohydrate of iGb3.
    Cameron G; Cheng JMH; Godfrey DI; Timmer MSM; Stocker BL; Dangerfield EM
    RSC Adv; 2022 Jun; 12(29):18493-18500. PubMed ID: 35799937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An expanding role for apolipoprotein E in sepsis and inflammation.
    Chuang K; Elford EL; Tseng J; Leung B; Harris HW
    Am J Surg; 2010 Sep; 200(3):391-7. PubMed ID: 20409531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor bone marrow type II (non-Valpha14Jalpha18 CD1d-restricted) NKT cells suppress graft-versus-host disease by producing IFN-gamma and IL-4.
    Kim JH; Choi EY; Chung DH
    J Immunol; 2007 Nov; 179(10):6579-87. PubMed ID: 17982047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of γδ T cells in α-galactosylceramide-mediated immunity.
    Paget C; Chow MT; Duret H; Mattarollo SR; Smyth MJ
    J Immunol; 2012 Apr; 188(8):3928-39. PubMed ID: 22412194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexes.
    Arora P; Kharkwal SS; Ng TW; Kunnath-Velayudhan S; Saini NK; Johndrow CT; Chang YT; Besra GS; Porcelli SA
    Chem Phys Lipids; 2015 Oct; 191():75-83. PubMed ID: 26306469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry.
    Li Y; Zhou D; Xia C; Wang PG; Levery SB
    Glycobiology; 2008 Feb; 18(2):166-76. PubMed ID: 18048405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.